BORRELIABAKTEERIN AIHEUTTAMA PARKINSONIN TAUTI

Voiko Borrelioosiin/lisäinfektioihin kuolla?

Valvojat: Borrelioosiyhdistys, Bb, Jatta1001

Vastaa Viestiin
soijuv
Viestit: 3151
Liittynyt: Ke Tammi 21, 2009 14:16

BORRELIABAKTEERIN AIHEUTTAMA PARKINSONIN TAUTI

Viesti Kirjoittaja soijuv » Su Syys 06, 2009 23:44

Borreliabakteeri aiheutti Parkinson taudin 63-vuotiaalle miehelle. Miehellä oli borreliabakteerin aiheuttama ihomuutos (erythema migrans), nivelkipuja ja vapinaa. Seerumi ja selkäydinestenäytteet olivat positiiviset. Antibioottihoidoista huolimatta potilas menehtyi v. 2001.


Lyme-associated parkinsonism: a neuropathologic case study and review of the literature.
Cassarino DS, Quezado MM, Ghatak NR, Duray PH.
Arch Pathol Lab Med, 127(9):1204-6. 2003.

Neurological complications of Lyme disease include meningitis, encephalitis, dementia, and, rarely, parkinsonism. We present a case of striatonigral degeneration, a form of multiple system atrophy, in Lyme-associated parkinsonism. A 63-year-old man presented with erythema migrans rash, joint pains, and tremors. Serum and cerebrospinal fluid antibodies and polymerase chain reaction for Borrelia burgdorferi were positive. Clinical parkinsonism was diagnosed by several neurologists. Despite treatment, the patient continued to decline, with progressive disability, cognitive dysfunction, rigidity, and pulmonary failure. At autopsy, the brain showed mild basal ganglia atrophy and substantia nigra depigmentation, with extensive striatal and substantia nigral neuronal loss and astrogliosis. No Lewy bodies were identified; however, ubiquitin-positive glial cytoplasmic inclusions were identified in striatal and nigral oligodendroglia. There were no perivascular or meningeal infiltrates, the classic findings of neuroborreliosis. To our knowledge, this is the first report of striatonigral degeneration in a patient with B burgdorferi infection of the central nervous system and clinical Lyme-associated parkinsonism.

Despite continued antibiotic treatments (IV vancomycin, azithromycin, and atovaquone), the patient's neurological status continued to decline, and he finally succumbed to infection and respiratory failure in April 2001.

Vastaa Viestiin